Good afternoon. Thanks Don. I'd like to start by running through our reported financial results for the fourth quarter and fiscal 2016 at a summary level. Fourth quarter total revenue declined 26%, $27.6 million versus a record $37.4 million in 2015. Fourth quarter net loss was $5.7 million, or $0.25 per share versus net income of $1.6 million or $0.07 per share last year. Fourth quarter adjusted EBITDA was negative $2.1 million compared to positive $5.4 million a year ago. We define adjusted EBITDA as net income or loss before interest, taxes, depreciation, amortization, stock-based compensation expense and other items that we do not believe are indicative of our core operating performance. Patent enforcement costs had a significant impact on both our net loss, adjusted EBITDA during the fourth quarter this year. We incurred $1.9 million of patent enforcement costs during the quarter versus $100,000 in the fourth quarter of last year. For the full year, total revenue declined 4% to $117.7 million. Net loss was $12 million for $0.52 per share in 2016 versus a net loss of $6.4 million or $0.28 per share last year. And adjusted EBITDA for the year was $3.9 million, down from $9.1 million in 2015. Patent enforcement costs, again, had a disproportionate impact on both our net loss and adjusted EBITDA during 2016. We incurred $3.6 million of patent enforcement cost during the year versus $200,000 in 2015. I'll now provide additional detail in the components of our results. First, I'll discuss revenue. Fourth quarter total revenue was comprised of product revenue of $27.2 million and research services revenue of $435,000. For the year, products revenue was $115.5 million and research services revenue was $2.2 million During the fourth quarter, product revenue decreased by $9.4 million, or 26% versus last year's record level of $36.6 million. This decline was driven by a significant decrease in Subsea revenue and continued weakness in the global downstream markets, offset in part by strong growth in shipments to the multiyear South Asia petrochemical project. In our view, the root cause of weak demand for our products continues to be constrained capital investment and low activity levels in our core energy markets. During the quarter, shipments increased 10% to 10.6 million square feet of Aerogel blankets, while our average selling price decreased by 17% $2.55 per square foot. This decrease in average selling price reflected a year-over-year decline in the mix of our higher price Subsea products in combination with an increase in revenue from the South Asia petrochemical project, which is characterized by project based pricing established in 2013, the high mix of lower priced 5-millimeter products. For the year, product revenue decreased by $5 million or 4% versus 2015. This decrease was driven by $20 million decline in our Subsea revenue year-over-year, offset in part by strong growth in shipments to the South Asia petrochemical project. Revenue from the South Asia petrochemical project doubled versus 2015 levels more than $29 million and comprised approximately 25% of our product revenue. For 2016 total blanket shipments increased by 5% to 44.3 million square feet, while our average selling price decreased by 8% versus a year ago to $2.61 per square foot. Again the decrease in average selling price reflected the year-over-year decline in the mix of our higher price subsea products in combination with the increase in revenue from the lower-priced South Asia petrochemical project. Looking forward, we anticipate that continued constrained capital investment and low activity levels in our energy markets and the conclusion of the South Asia petrochemical project lead to a decline in product revenue of 2017. As a result, we expect product revenue during 2017 of between $100 million and $110 million versus the $115.5 million generated during 2016. We expect our average selling price for the full year 2017 to increase to $2.75 per square foot plus or minus $0.10 due to the expected reduction in the mix of the lower-priced South Asia petrochemical project revenue and the impact of our 2017 price increases. This average selling price expectation is included in our 2017 annual revenue guidance. I'll now turn to our research services revenue. Our research services revenue is related to contract research performed principally for government agencies. By $300,000 decline in the fourth quarter of 2016, research revenue increased by 13% during the full year to $2.2 million. For 2017, we project that research services revenue will approximate $1.75 million. This estimate is also included in our 2017 revenue guidance. Next I'll turn to gross profit. Our gross profit $3.7 million and our gross margin of 13% during the fourth quarter represented a significant decrease from record levels in the fourth quarter of 2015. This decline in gross profit was driven by the 10% decline in shipment volume year-over-year, the unfavorable shift in mix from higher margin subsea revenue to the lower margin South Asia petrochemical project revenue, and a relative decrease in capacity utilization and manufacturing productivity during the fourth quarter this year from record levels last year. For the year, our gross margin of 20% was unchanged from 2015. However, gross profit dollars decreased by 5% to $23.3 million, due principally to the decline in revenue during the year. Again this revenue declined was due to the shift in mix from higher price subsea revenue to the lower priced South Asia petrochemical project business. Our gross profit and gross margin are highly dependent on product revenue and associated capacity utilization levels. Due to the high proportion of fixed costs in our manufacturing operations, we project that the percentage decrease in gross profit and gross margin during 2017 will exceed the expected percentage decrease in revenue during the year. As a reminder, our variable contribution margin is approximately 45% is a result the decrease in revenue and capacity utilization will lead to disproportionate decrease in both gross profit and gross margin. Accordingly, we expect gross margins to the decline to the mid-teens for 2017. This gross margin expectation is included in our 2017 guidance. I'd like to emphasize that we've not seen any significant change the economics of our business. Our value proposition remains strong and our product pricing, material cost, and manufacturing expenses are relatively stable. Projected decrease in gross margin in 2017 is principally a function of the expected decline in revenue volume and capacity utilization. Next I'll discuss operating expenses. Fourth quarter operating expenses grew by $1.3 million, or 16% to $9.4 million. This growth in operating expense was driven by $1.8 million increase in patent enforcement cost, offset in part by $500,000 year-over-year reduction in all other operating expenses during the quarter. For the year, operating expenses grew by $3.6 million, or 12%, $34.5 million. This increase in operating expenses was a result of a $3.3 million increase in patent enforcement costs and $1.2 million for increased investment in sales, personnel, and marketing programs, offset by a $900,000 year-over-year reduction in all other operating expenses, principally associated with decrease in incentive compensation. Looking forward, our 2017 guidance includes our expectation that operating expenses will increase by approximately 8% year-over-year. This projected operating expense increase reflects a planned increase in our research and development spending in sales personnel combined with a budgeted expense increase for incentive compensation, patent enforcement actions. Next, I'll discuss our balance sheet and cash flow. We ended 2016 with $18.1 million in cash at minimal debt, net current assets of $50.2 million, shareholders' equity of $115.6 million. In addition a $20 million revolving credit facility remains untapped. We recently extended the term of the facility through January 2018. I'll now provide our initial guidance for 2017. Total revenue is expected to range between $102 million to $112 million. Net loss is expected to range between $18.2 million to $21.2 million. Adjusted EBITDA is expected to range between a loss of $2 million and a loss of $5.4 million. EPS is expected to range between a loss of $0.78 a loss of $0.91 per share. This EPS guidance assumes weighted average of 23.4 million shares outstanding for the year. This 2017 outlook also assumes appreciation and amortization of between $10.6 million and $10.8 million, stock-based compensation of between $5 million and $5.2 million, and interest expense $200,000. In addition, this initial financial outlook includes between $3.9 million and $4.4 million of costs and expenses associated with our patent enforcement actions for the year. These patent enforcement costs will be frontloaded. We expect to incur 60% of the projected costs in the first quarter of 2017. But the remainder is spread over the final three quarters of the year. During 2017, we will focus on controlling capital expenditures maintain a strong balance sheet and financial flexibility. Our 2017 capital budget of approximately $7.3 million is comprised of $2 million in new projects to be initiated during the year and $5.3 million in final expenditures for the pilot line, for equipment and support of the new power market product, and for other projects approved and initiated during 2016. We expect capital expenditures will be frontload during the year with $6.2 million of spending projected for the first half of 2017. During the second half of the year, we plan to constrain capital expenditures to a level slightly greater than $0.5 million per quarter. Turning to cash at an aggregate level, we expect to use cash during the first half of 2017 to fund frontloaded operating losses, patent enforcement expenses, and capital expenditures. During the second half of the year, we expect to generate cash due to projected improvements in operating performance, anticipated declines in patent enforcement costs, our efforts to constrain new capital spending during the year. In the context of the range of our 2017 guidance, we expect to exit 2017 between $10 million and $14 million of cash on hand. While we don't plan to provide specific quarterly guidance on a routine basis, we think it's important from time-to-time to provide our investors with a general view to our expectations during the year. During 2017, our financial performance in the first quarter is expected to deviate from recent quarterly trends and to reflect the new floor for the company. As noted earlier in my comments, we expect revenue of between $102 million and $112 million for the full year. Within the scope of this annual guidance, we expect revenue of between $20 million and $24 million during the first quarter with growth expected from this space throughout the year. As I also noted earlier in my comments, we expect gross margins in the mid-teens for the full year. However, given the direct differential in quarterly revenue projections during the year, we expect gross margins of approximately 13% during the first quarter into the second quarter as well with improvements into the high-teens expected during the second half of the year. We also expect operating expense levels to be significantly higher in the first quarter of 2017 due to patent enforcement related expenses of between $2.3 million and $2.6 million during the period. Accordingly, we are projecting a first quarter adjusted EBITDA loss of approximately $4 million with improvement anticipated on a quarterly basis throughout the remainder of the year. This projected improvement reflects our general expectation of increasing revenue levels, proving gross margins, and decreasing IP enforcement costs over the final three quarters of the year. As always project work and product mix create quarterly variability, we will update our annual guidance at the time of each earnings release during 2017 or as otherwise necessary. I'll now turn the call back to Mariama for Q&A. Mariama?